Showing results (1751-1760 of 1,866) with videos related to

Sort By:
Pageof 187
Neurocritical Care|May 16, 2019
Common Data Elements for Unruptured Intracranial Aneurysms and Subarachnoid Hemorrhage Clinical Research: A National Institute for Neurological Disorders and Stroke and National Library of Medicine ProjectJose I Suarez, Muniza K Sheikh, R Loch Macdonald, et al.
Nano Letters|July 22, 2025
Magnetically Tunable Polariton Cavities in van der Waals HeterostructuresRafael A Mayer, Xinzhong Chen, Ran Jing, et al.
Cardiology in Review|December 28, 2022
Significant Mortality Associated With COVID-19 and Comorbid Cerebrovascular Disease: A Quantitative Systematic ReviewTolga Sursal, Chirag D Gandhi, Kevin Clare, et al.
The New England Journal of Medicine|February 21, 2019
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast CancerAditya Bardia, Ingrid A Mayer, Linda T Vahdat, et al.
AJNR. American Journal of Neuroradiology|April 23, 2021
Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort StudyF Al-Mufti, K Amuluru, R Sahni, et al.
JAMIA Open|November 29, 2023
Evaluating the impact of alternative phenotype definitions on incidence rates across a global data networkRupa Makadia, Azza Shoaibi, Gowtham A Rao, et al.
The Lancet. Oncology|May 9, 2016
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trialIan E Krop, Ingrid A Mayer, Vinod Ganju, et al.
Plos One|September 1, 2016
Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF ProjectGiuseppe Roberto, Ingrid Leal, Naveed Sattar, et al.
Journal of Intensive Care Medicine|April 2, 2025
Prediction of Mortality After Convulsive Status Epilepticus: The Status Epilepticus M<sup>3</sup>A<sup>2</sup>S<sup>2</sup>H ScoreFawaz Al-Mufti, Smit D Patel, Jonathan Ogulnick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell TransplantationSally Arai, Joseph Pidala, Iskra Pusic, et al.
Pageof 187